A history-dependent approach for accurate initial condition estimation in epidemic models.

A history-dependent approach for accurate initial condition estimation in epidemic models.

Publication date: Sep 05, 2025

Mathematical modeling is a powerful tool for understanding and predicting complex dynamical systems, ranging from gene regulatory networks to population-level dynamics. However, model predictions are highly sensitive to initial conditions, which are often unknown. In infectious disease models, for instance, the initial number of exposed individuals (E) at the time the model simulation starts is frequently unknown. This initial condition has often been estimated using an unrealistic, history-independent assumption for simplicity: the chance that an exposed individual becomes infectious is the same regardless of the timing of their exposure (i. e., exposure history). Here, we show that this history-independent method can yield serious bias in the estimation of the initial condition. To address this, we developed a history-dependent initial condition estimation method derived from a master equation expressing the time-varying likelihood of becoming infectious during a latent period. Our method consistently outperformed the history-independent method across various scenarios, including those with measurement errors and abrupt shifts in epidemics, for example, due to vaccination. In particular, our method reduced estimation error by 55% compared to the previous method in real-world COVID-19 data from Seoul, Republic of Korea, which includes likely infection dates, allowing us to obtain the true initial condition. This advancement of initial condition estimation enhances the precision of epidemic modeling, ultimately supporting more effective public health policies. We also provide a user-friendly package, Hist-D, to facilitate the use of this history-dependent initial condition estimation method.

Open Access PDF

Concepts Keywords
Epidemics Accurate
Informatics Condition
Outperformed Dependent
Seoul Epidemic
Vaccination Estimation
Exposed
Exposure
History
Independent
Infectious
Initial
Modeling
Models
Unknown

Semantics

Type Source Name
disease IDO history
disease MESH infectious disease
pathway REACTOME Infectious disease
disease MESH COVID-19
disease MESH infection
disease IDO process
drug DRUGBANK Coenzyme M
pathway REACTOME Reproduction
disease IDO contact tracing
disease MESH privacy
drug DRUGBANK Cysteamine
drug DRUGBANK Vildagliptin
drug DRUGBANK Aspartame
disease IDO symptom
drug DRUGBANK Polyethylene glycol
drug DRUGBANK L-Valine
disease IDO algorithm
disease IDO production
disease MESH uncertainty
drug DRUGBANK Potassium
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Flunarizine
drug DRUGBANK Dihydrostreptomycin
disease MESH community spread
drug DRUGBANK Sulfasalazine
disease MESH influenza
disease MESH monkeypox
disease IDO intervention
drug DRUGBANK Carboxyamidotriazole
disease MESH presymptomatic infection
pathway REACTOME Signal Transduction
disease MESH tumors

Original Article

(Visited 7 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *